TY  - GEN
AU  - Pinter,M
AU  - Sieghart,W
AU  - Hucke,F
AU  - Graziadei,I
AU  - Vogel,W
AU  - Maieron,A
AU  - Königsberg,R
AU  - Weissmann,A
AU  - Kornek,G
AU  - Matejka,J
AU  - Stauber,R
AU  - Buder,R
AU  - Grünberger,B
AU  - Schöniger-Hekele,M
AU  - Müller,C
AU  - Peck-Radosavljevic,M
TI  - Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
SN  - 1365-2036
PY  - 2012///0315
KW  - Administration, Oral
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Benzenesulfonates
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Liver Neoplasms
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Prognosis
KW  - Pyridines
KW  - Retrospective Studies
KW  - Severity of Illness Index
KW  - Sorafenib
KW  - Statistics as Topic
KW  - Survival Rate
KW  - Tomography, X-Ray Computed
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1111/j.1365-2036.2011.04823.x
ER  -